Annual long term liabilities:
$22.03M+$22.03M(+100.00%)Summary
- As of today (September 16, 2025), PTGX annual total long term liabilities is $22.03 million, with the most recent change of +$22.03 million (+100.00%) on December 31, 2024.
- During the last 3 years, PTGX annual long term liabilities has risen by +$18.37 million (+502.30%).
- PTGX annual long term liabilities is now -44.29% below its all-time high of $39.55 million, reached on December 31, 2019.
Performance
PTGX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$14.48M-$3.49M(-19.41%)Summary
- As of today (September 16, 2025), PTGX quarterly total long term liabilities is $14.48 million, with the most recent change of -$3.49 million (-19.41%) on June 30, 2025.
- Over the past year, PTGX quarterly long term liabilities has dropped by -$17.25 million (-54.36%).
- PTGX quarterly long term liabilities is now -59.62% below its all-time high of $35.86 million, reached on March 31, 2020.
Performance
PTGX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PTGX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -54.4% |
| 3 y3 years | +502.3% | +492.0% |
| 5 y5 years | -44.3% | -34.6% |
PTGX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -54.4% | >+9999.0% |
| 5 y | 5-year | -44.3% | >+9999.0% | -54.4% | >+9999.0% |
| alltime | all time | -44.3% | >+9999.0% | -59.6% | >+9999.0% |
PTGX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $14.48M(-19.4%) |
| Mar 2025 | - | $17.97M(+30.4%) |
| Dec 2024 | $22.03M(>+9900.0%) | $13.78M(-49.6%) |
| Sep 2024 | - | $27.36M(-13.8%) |
| Jun 2024 | - | $31.73M(+9.7%) |
| Mar 2024 | - | $28.92M(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $221.00K(>+9900.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $462.00K(-59.5%) |
| Dec 2022 | $1.14M(-68.8%) | $1.14M(-36.8%) |
| Sep 2022 | - | $1.80M(-26.2%) |
| Jun 2022 | - | $2.45M(-20.1%) |
| Mar 2022 | - | $3.06M(-16.3%) |
| Dec 2021 | $3.66M(-20.8%) | $3.66M(-16.1%) |
| Sep 2021 | - | $4.36M(+14.3%) |
| Jun 2021 | - | $3.81M(-9.7%) |
| Mar 2021 | - | $4.22M(+263.7%) |
| Dec 2020 | $4.62M | $1.16M(-87.3%) |
| Sep 2020 | - | $9.17M(-58.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $22.14M(-38.3%) |
| Mar 2020 | - | $35.86M(+43.1%) |
| Dec 2019 | $39.55M(+4849.6%) | $25.06M(-12.0%) |
| Sep 2019 | - | $28.49M(-6.5%) |
| Jun 2019 | - | $30.47M(+340.0%) |
| Mar 2019 | - | $6.92M(+766.6%) |
| Dec 2018 | $799.00K(+46.1%) | $799.00K(+0.3%) |
| Sep 2018 | - | $797.00K(+0.5%) |
| Jun 2018 | - | $793.00K(+14.3%) |
| Mar 2018 | - | $694.00K(+26.9%) |
| Dec 2017 | $547.00K(>+9900.0%) | $547.00K(+64.8%) |
| Sep 2017 | - | $332.00K(+300.0%) |
| Jun 2017 | - | $83.00K(>+9900.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(-100.0%) |
| Mar 2016 | - | $1.00M(-52.7%) |
| Dec 2015 | $2.12M(+107.5%) | $2.12M |
| Dec 2014 | $1.02M | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Protagonist Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of PTGX is $22.03M
What is the all time high annual long term liabilities for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual total long term liabilities is $39.55M
What is Protagonist Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, PTGX annual total long term liabilities has changed by +$22.03M (+100.00%)
What is Protagonist Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of PTGX is $14.48M
What is the all time high quarterly long term liabilities for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly total long term liabilities is $35.86M
What is Protagonist Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, PTGX quarterly total long term liabilities has changed by -$17.25M (-54.36%)